Clinical Trials Browser

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Colorectal Neoplasms

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

Liver Neoplasms

Esophageal Squamous Cell Carcinoma

Anemia, Refractory, with Excess of Blasts, Myeloproliferative Disorders

HER2-positive Breast Cancer

Fallopian Tube Neoplasms

Prostatic Neoplasms

Recurrence, Lymphoma, Large B-Cell, Diffuse

Colorectal Cancer Metastatic

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell, Kidney Neoplasms

Lymphoma, Non-Hodgkin

Burkitt Lymphoma

Breast Neoplasms, Stomach Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lung Neoplasms

Mycosis Fungoides

Urinary Bladder Neoplasms, Ureteral Neoplasms

Platinum-Refractory Fallopian Tube Carcinoma

Fallopian Tube Neoplasms, Ovarian Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Breast Neoplasms

Neoplasm Metastasis

Endometrial Neoplasms

Carcinoma, Hepatocellular, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Leukemia, Myeloid, Acute

Lymphoma, B-Cell

Lymphoma, Non-Hodgkin

Carcinoma, Merkel Cell

Carcinoma, Non-Small-Cell Lung

Colorectal Neoplasms

Carcinoma, Transitional Cell

Colonic Neoplasms

Prostatic Neoplasms

Adenoma, Islet Cell, Pancreatic Neoplasms

Hodgkin Disease, Lymphoma, Mucositis

Select Advanced Solid Tumors

Leukemia, Myeloid, Acute

Metastatic Urothelial Cancer

Carcinoma, Non-Small-Cell Lung

Prostatic Neoplasms

Leukemia, Myeloid, Acute

Esophageal Neoplasms, Neoplasms

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma

Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Mantle-Cell

Hamartoma Syndrome, Multiple

Clinical Trials

A Clinical Study of CAR-T Treating Relapsed or Refractory T Cell Lymphoblastic Acute Leukemia/ Lymphoma

A Trial of Regorafenib Plus Lorigerlimab as Neoadjuvant Therapy for Patients With pMMR/MSS, Resectable, Lung-limited Metastatic Colorectal Cancer

CheckCell-2

BC3402 w/ Tremelimumab + Durvalumab (STRIDE) in Hepatocellular Carcinoma

S095033 in Combination With Paclitaxel as 2nd- or 3rd-line Treatment in Participants With Advanced or Metastatic ESCC

Phase I/II Study of a Combination of Decitabine and Cedazuridine (ASTX727) and ASTX029, an ERK Inhibitor, for Patients With RAS Pathway Mutant Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms

Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients With Advanced PET/MR Imaging

A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer

NovoTTF-200A + Pembrolizumab In Melanoma Brain Metastasis

NeoPSMA

Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL)

LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615)

PSMA Therapy and Immunotherapy in Kidney Cancer

Clinical Trial of HY004 Cell Injection in the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

B-ALL

A Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid Tumors

Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS

BIOSELECT

Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer

Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer

Niraparib and Selenium for the Treatment of Recurrent BRCA Negative Platinum Resistant Ovarian Cancer

Birinapant and Carboplatin in Treating Patients and Targeting Recurrent High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (HGSOC)

Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer

MK-9999-01B

LiDer

TT-4 As a Single Agent in Subjects with Advanced Selected Solid Tumors

A Phase 1B/2A Trial of Combination of ASTX727 With ASTX029 in Acute Myeloid Leukemia

Assessing an Oral Bruton Tyrosine Kinase Inhibitor, DZD9008 in Patients Who Have Non-Hodgkin B-cell Lymphoma (WU-KONG3)

QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHL

QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 Therapy

QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 Therapy

QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors

QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC

QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy

QUILT-3.091 NANT Chordoma Vaccine vs Radiation in Subjects With Unresectable Chordoma.

Panitumumab

Lenvatinib, Pembrolizumab, and Tumor Treating Fields (TTFields) for Second-line Treatment of Glioblastoma

A Study of Copanlisib in Combination with Degarelix in People with Prostate Cancer

Preoperative PRRT Versus Surgical Cytoreduction in Metastatic Pancreatic Neuroendocrine Tumors to the Liver

Safety, Tolerability, PK/PD of FE 203799 in Adults With Lymphomas

Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab

Induction Therapy for Patients With FLT3 Mutated Acute Myeloid Leukemia

MANHATTAN

HAITEN-ICI

LUNAAR

Tislelizumab with Azacitidine in the Treatment of R/R AML

Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With Entinostat and Nivolumab as Adjuvant Therapy Following Chemoradiation Therapy With or Without Surgery for Locally Advanced Esophageal Cancer

Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Advanced Cutaneous Melanoma

Interferon-Beta-1a (FP-1201) to Prevent Toxicities After CD19-Directed CAR T-Cell Therapy

Sirolimus for Improving Social Abilities in People With PTEN Germline Mutations